TR200000536A2 - Büyüme hormonu sekretagogları hazırlamak için proses. - Google Patents

Büyüme hormonu sekretagogları hazırlamak için proses.

Info

Publication number
TR200000536A2
TR200000536A2 TR2000/00536A TR200000536A TR200000536A2 TR 200000536 A2 TR200000536 A2 TR 200000536A2 TR 2000/00536 A TR2000/00536 A TR 2000/00536A TR 200000536 A TR200000536 A TR 200000536A TR 200000536 A2 TR200000536 A2 TR 200000536A2
Authority
TR
Turkey
Prior art keywords
growth hormone
hormone secretagogues
preparing growth
preparing
compounds
Prior art date
Application number
TR2000/00536A
Other languages
English (en)
Inventor
Robert Busch Frank
Kwok-Fung Chiu Charles
Nathaniel Meltz Clifford
James Post Ronald
Robert Rose Peter
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200000536A2 publication Critical patent/TR200000536A2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Bu bulus, asagidaki Formül II' ye sahip bilesikleri ve asagidaki Formül III'e sahip bilesikleri hazirlamaya yönelik iyilestirilmis proseslere iliskindir; yukaridaki formüllerde R , R , R ve Prt, tarifnamede tanimlandiklari gibidir.
TR2000/00536A 1999-02-26 2000-02-25 Büyüme hormonu sekretagogları hazırlamak için proses. TR200000536A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26

Publications (1)

Publication Number Publication Date
TR200000536A2 true TR200000536A2 (tr) 2000-09-21

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00536A TR200000536A2 (tr) 1999-02-26 2000-02-25 Büyüme hormonu sekretagogları hazırlamak için proses.

Country Status (44)

Country Link
US (2) US6541634B2 (tr)
EP (2) EP1449842A1 (tr)
JP (3) JP3437813B2 (tr)
KR (2) KR100372063B1 (tr)
CN (3) CN1515570A (tr)
AP (1) AP1221A (tr)
AR (2) AR029617A1 (tr)
AT (1) ATE277944T1 (tr)
AU (1) AU764122B2 (tr)
BG (1) BG104175A (tr)
BR (2) BRPI0017522B8 (tr)
CA (1) CA2299495C (tr)
CO (1) CO5160252A1 (tr)
DE (1) DE60014212T2 (tr)
DK (1) DK1031575T3 (tr)
DZ (1) DZ3018A1 (tr)
EA (1) EA003218B1 (tr)
EE (1) EE200000193A (tr)
ES (1) ES2226712T3 (tr)
GT (1) GT200000018A (tr)
HK (1) HK1030219A1 (tr)
HN (1) HN2000000021A (tr)
HR (1) HRP20000103A2 (tr)
HU (1) HUP0000907A3 (tr)
ID (1) ID24861A (tr)
IL (2) IL134599A (tr)
IN (1) IN192352B (tr)
IS (1) IS5380A (tr)
MA (1) MA25072A1 (tr)
NO (1) NO20000965L (tr)
NZ (1) NZ503062A (tr)
OA (1) OA11325A (tr)
PA (1) PA8491201A1 (tr)
PE (1) PE20001550A1 (tr)
PL (1) PL338628A1 (tr)
PT (1) PT1031575E (tr)
SG (1) SG90096A1 (tr)
SI (1) SI1031575T1 (tr)
SK (1) SK284982B6 (tr)
TN (1) TNSN00035A1 (tr)
TR (1) TR200000536A2 (tr)
TW (2) TW200718702A (tr)
UA (1) UA70306C2 (tr)
ZA (1) ZA200000888B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
AU2001264977B2 (en) 2000-05-30 2005-04-14 Merck & Co., Inc. Melanocortin receptor agonists
AU2003237595A1 (en) * 2003-05-26 2004-12-13 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
RU2670978C9 (ru) * 2013-05-28 2018-11-22 Раквалиа Фарма Инк. Полиморфные формы
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5578593A (en) 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
CN1174504A (zh) 1993-11-09 1998-02-25 麦克公司 促进生长激素释放的哌啶、吡咯烷和六氢－1h－吖庚因
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
AU2722297A (en) 1996-04-03 1997-10-22 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
AU7445498A (en) 1997-06-25 1999-01-04 Pfizer Inc. Dipeptide derivatives as growth hormone secretagogues
UA64751C2 (uk) 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)

Also Published As

Publication number Publication date
EA200000172A3 (ru) 2000-10-30
AP2000001754A0 (en) 2000-03-31
US20030158414A1 (en) 2003-08-21
SK2302000A3 (en) 2000-11-07
TNSN00035A1 (fr) 2005-11-10
HUP0000907A3 (en) 2001-05-28
KR100361783B1 (ko) 2002-11-22
CN1837205A (zh) 2006-09-27
HN2000000021A (es) 2001-02-02
DE60014212T2 (de) 2005-12-15
EA003218B1 (ru) 2003-02-27
DZ3018A1 (fr) 2004-03-20
BRPI0017522B8 (pt) 2021-05-25
AP1221A (en) 2003-11-03
AR053722A2 (es) 2007-05-16
IL157103A (en) 2007-07-24
EA200000172A2 (ru) 2000-08-28
ATE277944T1 (de) 2004-10-15
IN192352B (tr) 2004-04-10
CN1137891C (zh) 2004-02-11
PE20001550A1 (es) 2001-01-11
HUP0000907A2 (en) 2001-03-28
DE60014212D1 (de) 2004-11-04
CA2299495C (en) 2010-06-15
ES2226712T3 (es) 2005-04-01
PA8491201A1 (es) 2001-04-30
CN1515570A (zh) 2004-07-28
BRPI0000967A (pt) 2001-09-11
SI1031575T1 (en) 2005-02-28
KR20020065455A (ko) 2002-08-13
SG90096A1 (en) 2002-07-23
JP2003327585A (ja) 2003-11-19
NZ503062A (en) 2001-07-27
GT200000018A (es) 2001-08-16
KR20010006698A (ko) 2001-01-26
IL134599A0 (en) 2001-04-30
NO20000965L (no) 2000-08-28
ID24861A (id) 2000-08-31
DK1031575T3 (da) 2005-01-03
IL157103A0 (en) 2004-02-08
CN1270960A (zh) 2000-10-25
JP2000247974A (ja) 2000-09-12
OA11325A (en) 2003-10-27
TW200718702A (en) 2007-05-16
MA25072A1 (fr) 2000-10-01
BRPI0000967B8 (pt) 2021-12-07
PL338628A1 (en) 2000-08-28
NO20000965D0 (no) 2000-02-25
TWI286142B (en) 2007-09-01
BRPI0017522B1 (pt) 2013-09-24
JP3437813B2 (ja) 2003-08-18
BRPI0017522A2 (tr) 2009-12-22
AU764122B2 (en) 2003-08-07
IS5380A (is) 2000-08-27
IL134599A (en) 2006-12-10
JP2003261565A (ja) 2003-09-19
CO5160252A1 (es) 2002-05-30
HU0000907D0 (en) 2000-04-28
BRPI0000967B1 (pt) 2012-06-12
ZA200000888B (en) 2001-08-23
US6541634B2 (en) 2003-04-01
US6673929B2 (en) 2004-01-06
SK284982B6 (sk) 2006-03-02
JP4051314B2 (ja) 2008-02-20
US20020002283A1 (en) 2002-01-03
HRP20000103A2 (en) 2001-04-30
AU1947100A (en) 2000-08-31
EP1031575A1 (en) 2000-08-30
HK1030219A1 (en) 2001-04-27
EE200000193A (et) 2000-10-16
EP1031575B1 (en) 2004-09-29
BG104175A (bg) 2000-12-29
CA2299495A1 (en) 2000-08-26
EP1449842A1 (en) 2004-08-25
KR100372063B1 (ko) 2003-02-14
AR029617A1 (es) 2003-07-10
PT1031575E (pt) 2004-11-30
UA70306C2 (en) 2004-10-15

Similar Documents

Publication Publication Date Title
ATE469892T1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
ATE290059T1 (de) Tensidzusammensetzung enthaltend geminitenside und co-amphiphile, ihre herstellung und ihre verwendung
TR200101709T2 (tr) İltihabik hastalıkların tedavisinde yararlı olan bileşikler
DZ3482A1 (fr) Secretagogues de l'hormone de croissance
TR199900920T2 (tr) Nafthiridin türevleri.
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
BG103485A (en) Ketobanzamides as calpain inhibitors
CR6540A (es) Trifluorobutenos nematicidas
IN2012DE00109A (tr)
PL344475A1 (en) Bridged indenopyrrolocarbazoles
DE60112330D1 (en) Pyrazolopyridinderivate
TR199902879A2 (tr) Büyüme hormonu sekratagoglari için süreç ve aracilar.
TR200000536A2 (tr) Büyüme hormonu sekretagogları hazırlamak için proses.
BG105766A (en) New process for preparing pesticidal intermediates
PT1204659E (pt) Benzofuranos serotoninergicos
MXPA04000036A (es) Benzofuranos sustituidos con (hetero) arilo como ligandos 5-ht.
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
TR200100286T2 (tr) (1H)-Benzo[C]kuinolizin-3-on türevlerinin sentezi için proses.
ID27440A (id) Proses untuk menyiapkan penengah-penengah
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
BR9808210A (pt) Befeniloxazolinas dissubstituìdas
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
YU52700A (sh) Postupak za pripremanje stimulatora lučenja hormona rasta
DE59914314D1 (de) 2,3,3a,4,9,9a-HEXAHYDRO-8-HYDROXY-1H-BENZÄFÜINDOLE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARZNEIMITTEL
ATE239015T1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung